Fibroblast activation protein constitutes a novel target of chimeric antigen receptor T‐cell therapy in solid tumors

Documents similaires

• Fat and proteolysis due to methionine, tryptophan, and niacin deficiency leads to alterations in gut microbiota and immune modulation in inflammatory bowel disease
  par: Tomoaki Hara, et autres
  Publié: (2024)
• RNA methylation in inflammatory bowel disease
  par: Yuki Ozato, et autres
  Publié: (2024)
• Recent Findings in N6‐Methyladenosine Modification and Significance in Pancreatic Cancer
  par: Tomoaki Hara, et autres
  Publié: (2025)
• Advances in research on factors affecting chimeric antigen receptor T‐cell efficacy
  par: Delian Zhou, et autres
  Publié: (2024)
• Indicators describing the tumor lesion aggregation and dissemination and their impact on the prognosis of patients with diffuse large B cell lymphoma receiving chimeric antigen receptor T cell therapy
  par: Xiuyong Dang, et autres
  Publié: (2024)